Kumarasamy, Nagalingeswaran

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 6,873

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,700

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

Matthews, G., Jacoby, S., Borok, M., Eriobu, N., Kaplan, R., Kumarasamy, N., Bennet, J. A., Avihingsanon, A., Chetchotisakd, P., Wagner Cardoso, S., et al. (2024) · The Lancet HIV

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 31

Value of single acid-fast bacilli sputum smears in the diagnosis of tuberculosis in HIV-positive subjects

Vignesh, R., Balakrishnan, P., Shankar, E. M., Gangatharan Murugavel, K., Hanas, S., Cecelia, A. J., Solomon, S., & Kumarasamy, N. (2007) · Journal of Medical Microbiology

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 27